The stage of chemotherapy in children with ALL is a long process, and the myocardial damage caused by chemotherapy is still unknown. The different chemotherapy stages may have different degrees of myocardial damage. In this study, cardiac magnetic resonance was used to evaluate myocardial strain in ALL patients at different stages of treatment, and it was found that myocardial strain reduction was more pronounced in the early stages of treatment, and that global strain was a risk factor for adverse clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: